Defence Therapeutics (TSE:DTC) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Defence Therapeutics Inc., a Canadian biopharmaceutical company, has announced a private placement of up to $4.2 million to support its preclinical and clinical programs. The offering consists of seven million units, each comprising a common share and a warrant, aimed at advancing the company’s innovative radiopharmaceutical and ADC products.
For further insights into TSE:DTC stock, check out TipRanks’ Stock Analysis page.
